Drug trafficking and counter-drug policies in Latin America are undoubtedly challenging and important topics for both scholars and policy analysts. Consider, for instance, the tremendous drug-related bloodshed Mexico is currently witnessing or Colombia's ongoing violence stemming from protracted internal armed conflict and pervasive crime, both in large part fuelled by drug money. For years governments in Europe, the United States, Canada and Latin America have been spending billions on controlling cocaine, both supply and demand, but all available evidence suggests that the existing programmes and policies are not having a lasting and positive impact. In effect, UN statistics show that in the last decade total potential cocaine production in Bolivia, Colombia and Peru, the world's three principal producing countries, has not varied a great deal. Cocaine demand continues to be high in the United States and is increasing in some European and Latin American countries, and the drug-trafficking organisations, which are becoming ever more globalised, are demonstrating that they are quite capable of withstanding the authorities' law enforcement and interdiction efforts by constantly adjusting their trafficking methods and routes, and forming new alliances with each other.
Many books, articles and policy reports have been written on these issues in the past years and decades. Nonetheless, the dynamic, large-scale and persistent nature of drug trafficking and the challenges it poses for European and US counter-drug and security policy, as well as Latin America's democracies and societies, make it a worthwhile subject for further enquiry. The questions of why it has been impossible thus far to achieve a more coordinated and effective policy response from Europe, the United States and Latin America to the global problem of cocaine trafficking and what should be done to improve this situation continue to be important today. Sayaka Fukumi's book tries to provide answers, but ultimately falls short of moving the present discussion forward. It should suffice here to refer to three central aspects of my critical reading of the study.
The first fundamental observation is that there is nothing much new in the book, which, by the way, would have benefited from a thorough revision with respect to language and style. The author's extensive discussion of the different forms of ‘securitization’ of drug control policy and cocaine trafficking in the European Union and the United States does not really provide fresh insights. According to the study, Europe perceives the production and trafficking of Andean cocaine as a ‘societal threat’ and the United States regards it as a ‘national security threat’. In consequence, Europe has favoured policies focused on contributing to economic and social development in the source countries, and has been implementing a variety of ‘soft’ as well as ‘hard’ demand reduction strategies at home. The United States, in turn, has placed emphasis on the forced eradication of coca crops in the source countries and heavy-handed law enforcement and interdiction in the Andes, the transit countries and domestically. While these are already well-established facts, it would have been interesting if Fukumi had made a more systematic effort to explain the institutional and political constraints and variables shaping both European and US drug control policies. In this regard it is surprising, for example, that there is no structured analysis of the differences in approach to drug control policy that exist within the EU, to which the author erroneously refers as an ‘international organization’ (p. 112), and among its member states. Another interesting issue would have been to explore why Europeans and North Americans are hardly talking to each other about drug control policy, and why they have largely refrained from sharing experiences.
My second observation is that Fukumi apparently did not inform himself with sufficient rigour about the situation in Bolivia, Colombia and Peru. In fact, judging by the list of interviews included in the book, it appears that no fieldwork was conducted in the Andean region. This seems a major omission and could explain why the author seems to be rather unfamiliar with European and US programmes in the Andes – especially Plan Colombia and the EU's Colombian Peace Laboratories, both of which receive much more attention than other programmes in Bolivia and Peru – and the complex ramifications and ideological-political underpinnings of the heated debates about them. For example, the opening paragraph in chap. 6 reads, ‘Plan Colombia is the first programme designed for drug control through multilateral cooperation … that aims at … a balance between law enforcement and economic and social development’. Considering that two of the main shortcomings of Plan Colombia are precisely that, for political reasons, it ended up not being a multilateral, but only a bilateral, US–Colombian counter-drug and counter-insurgency programme, and that it did not strike a balance between aerial eradication of coca crops and law enforcement on the one hand, and alternative institutional and socio-economic development on the other, it becomes clear that the author lacks sufficient empirical perspective.
Finally, any new contribution to the field of counter-drug policy in Latin America should, in one way or another, provide answers to the question of what can and should be done differently and better. In the concluding chapter of his book, Fukumi highlights the need for more multinational cooperation in drug control policy and more commitment in the United States, Europe and Latin America to working with others who hold different views on the threat posed by cocaine trafficking. This is important, but it is not enough and, as things stand, probably also not feasible. Today's ineffective, fragmented and harmful international counter-drug policy is in dire need of a thorough overhaul, which necessarily has to be based on broad international consensus on how to deal with drugs, drug trafficking and drug use in general. Establishing such a consensus would have to include resolving the issue of diverging threat perceptions, but the end goal would be to ‘de-securitize’ the global drug issue and lay the foundations for the sensible and humane treatment of what is essentially a social and public health concern.
